(Q42549394)

2 November 2017

title

Escape mutants of HIV-1 proteinase: enzymic efficiency and susceptibility to inhibition (English)

1 reference

2 November 2017

S I Wilson

1

1 reference

2 November 2017

L H Phylip

2

1 reference

2 November 2017

J S Mills

3

1 reference

2 November 2017

S V Gulnik

4

1 reference

2 November 2017

J W Erickson

5

1 reference

2 November 2017

B M Dunn

6

1 reference

2 November 2017

J Kay

7

1 reference

2 November 2017

publication date

1 April 1997

1 reference

Biochimica et Biophysica Acta

2 November 2017

published in

1 reference

2 November 2017

volume

1339

1 reference

2 November 2017

issue

1

1 reference

2 November 2017

page(s)

113-125

1 reference

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Subsite preferences of retroviral proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

The selectivity of statine-based inhibitors against various human aspartic proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Proteolytic Processing of Particle-Associated Retroviral Polyproteins by Homologous and Heterologous Viral Proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Scintillation Proximity Enzyme Assay a Rapid and Novel Assay Technique Applied to HIV Proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

The not-so-great escape

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Dissociation and association of the HIV-1 protease dimer subunits: equilibria and rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Stabilization of HIV proteinase dimer by bound substrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Structure of equine infectious anemia virus proteinase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Standardized and simplified nomenclature for proteins common to all retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2896%2900224-5

7 January 2021

10.1016/S0167-4838(96)00224-5

Identifiers

DOI

1 reference

2 November 2017

1 reference